Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
20/11/2025 21:36
Nov 20 (Reuters) - Innocan Pharma Corp IP40.F: INNOCAN PHARMA ANNOUNCES PROMISING RESULTS OF LPT-CBD ADMINISTERED TO GOTTINGEN MINIPIGS, A WELL-KNOWN DRUG TOXICOLOGY MODEL Source text: ID:nPresGrsNa Further company coverage: IP40.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation